Literature DB >> 19957009

Multiple sclerosis attacks triggered by hyperprolactinemia.

V Nociti1, G Frisullo, T Tartaglione, A K Patanella, R Iorio, P A Tonali, A P Batocchi.   

Abstract

Multiple sclerosis (MS) is a T-cell autoimmune disease of the central nervous system (CNS). Predominance of women in autoimmune diseases suggests that sex hormones may play a role in disease susceptibility. A possible role for prolactin, a neuroendocrine peptide with powerful immunomodulatory properties, is suggested in MS. We describe the case of a 32-year-old man affected by relapsing-remitting MS who experienced the first MS clinical event during the development of a prolactin-secreting adenoma and the only two MS relapses during adenoma recurrence. Prolactin may have facilitated the inflammatory process and triggered MS clinical attacks, suggesting a role of prolactin in immunomodulation and therefore in autoimmune disease course.

Entities:  

Mesh:

Year:  2009        PMID: 19957009     DOI: 10.1007/s11060-009-0076-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  12 in total

Review 1.  Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease.

Authors:  Howard L Weiner
Journal:  Arch Neurol       Date:  2004-10

2.  Bromocriptine therapy in multiple sclerosis: an open label pilot study.

Authors:  V Bissay; N De Klippel; L Herroelen; E Schmedding; T Buisseret; G Ebinger; J De Keyser
Journal:  Clin Neuropharmacol       Date:  1994-10       Impact factor: 1.592

3.  White matter plasticity and enhanced remyelination in the maternal CNS.

Authors:  Christopher Gregg; Viktor Shikar; Peter Larsen; Gloria Mak; Andrew Chojnacki; V Wee Yong; Samuel Weiss
Journal:  J Neurosci       Date:  2007-02-21       Impact factor: 6.167

4.  Prolactin modulates the functions of murine spleen CD11c-positive dendritic cells.

Authors:  Linsong Yang; Yali Hu; Xiaoxi Li; Junli Zhao; Yayi Hou
Journal:  Int Immunopharmacol       Date:  2006-05-30       Impact factor: 4.932

5.  Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse.

Authors:  Sandra Vukusic; Michael Hutchinson; Martine Hours; Thibault Moreau; Patricia Cortinovis-Tourniaire; Patrice Adeleine; Christian Confavreux
Journal:  Brain       Date:  2004-05-06       Impact factor: 13.501

6.  The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine.

Authors:  P N Riskind; L Massacesi; T H Doolittle; S L Hauser
Journal:  Ann Neurol       Date:  1991-05       Impact factor: 10.422

7.  Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis.

Authors:  Annette Langer-Gould; Stella M Huang; Rohit Gupta; Amethyst D Leimpeter; Eleni Greenwood; Kathleen B Albers; Stephen K Van Den Eeden; Lorene M Nelson
Journal:  Arch Neurol       Date:  2009-06-08

Review 8.  The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?

Authors:  Howard L Weiner
Journal:  Ann Neurol       Date:  2009-03       Impact factor: 10.422

9.  Prolactin induced production of cytokines in macrophages involves Ca++ and p42/44 MAP kinase signaling pathway.

Authors:  Ajit Sodhi; Anurag Tripathi
Journal:  Growth Factors       Date:  2008-08       Impact factor: 2.511

10.  Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.

Authors:  Florian Then Bergh; Tania Kümpfel; Erina Schumann; Ulrike Held; Michaela Schwan; Mirjana Blazevic; Axel Wismüller; Florian Holsboer; Alexander Yassouridis; Manfred Uhr; Frank Weber; Martin Daumer; Claudia Trenkwalder; Dorothee P Auer
Journal:  BMC Neurol       Date:  2006-05-23       Impact factor: 2.474

View more
  5 in total

1.  Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients.

Authors:  Hedi Orbach; Gisele Zandman-Goddard; Mona Boaz; Nancy Agmon-Levin; Howard Amital; Zoltan Szekanecz; Gabriella Szucs; Josef Rovensky; Emese Kiss; Andrea Doria; Anna Ghirardello; Jesus Gomez-Arbesu; Ljudmila Stojanovich; Francesca Ingegnoli; Pier Luigi Meroni; Blaz' Rozman; Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 2.  Sex-related factors in multiple sclerosis susceptibility and progression.

Authors:  Rhonda R Voskuhl; Stefan M Gold
Journal:  Nat Rev Neurol       Date:  2012-03-27       Impact factor: 42.937

3.  Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas.

Authors:  V Larouche; J A Correa; P Cassidy; C Beauregard; N Garfield; J Rivera
Journal:  Pituitary       Date:  2016-04       Impact factor: 4.107

Review 4.  Prolactin: Friend or Foe in Central Nervous System Autoimmune Inflammation?

Authors:  Massimo Costanza; Rosetta Pedotti
Journal:  Int J Mol Sci       Date:  2016-12-02       Impact factor: 5.923

5.  Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis.

Authors:  L De Giglio; F Marinelli; L Prosperini; G M Contessa; F Gurreri; M C Piattella; F De Angelis; V T Barletta; V Tomassini; P Pantano; C Pozzilli
Journal:  Mediators Inflamm       Date:  2015-07-08       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.